Caduceus Capital Partners Leads Seed Round for Health Screening Startup Reperio Health

Mar 8, 2021 | Press Release

Reperio Health, the only at-home health assessment and biometric screening system that provides comprehensive results immediately, announced its seed capital raise of $3 million. The round was co-led by Caduceus Capital Partners and Rogue Venture Partners. The raise supports plans to accelerate growth and expand proactive health monitoring to the employer market.

Reperio’s patent-pending at-home health assessment enables individuals to perform a broad range of screenings at their convenience while in the comfort of their own home. The FDA-approved sensors in the Reperio kit include a blood test to measure levels of total cholesterol, HDL, LDL, triglycerides and glucose, in addition to tests for blood pressure, resting heart rate, Body Mass Index (BMI) and Relative Fat Mass (RFM).

Along with their initial launch into the employer market, Reperio’s at-home health assessments will be made available to health plans, retirement facilities, fitness and nutrition practitioners and directly to individuals who are personally motivated to better understand and control their health data.

“Nearly 9 out of 10 large employers currently offer some sort of workplace wellness program, which equates to roughly 63 million people in the U.S. alone,” said Travis Rush, Reperio co-founder and CEO. “Unfortunately, the typical process for health screenings is time-consuming and inconvenient, so many people procrastinate and put these off for years. Reperio is making it easy by bringing health screenings right to peoples’ doors.”

“At Caduceus Capital Partners, we focus on the key factors driving healthcare disruption and transformation. We believe that in the near future, a majority of primary care will be virtual and occur within the home. In this age of ordering products to your doorstep in days or hours, it’s inevitable that comprehensive tech-enabled healthcare services will follow suit,” said Dave Vreeland, senior managing partner, Caduceus Capital Partners. “We’re proud to work with Reperio and believe their solution platform will revolutionize the way health testing is conducted for millions of individuals.”

Caduceus Capital Partner’s venture partner, Phil Hertik, will serve as a member of the five-person board of directors.

Reperio Health is based in Portland, Ore. Rush is the former CEO of Sightbox, which sold to Johnson & Johnson in 2017.

About Caduceus Capital Partners, LLC

Caduceus Capital Partners is a venture capital and private equity company focused on early stage digital health investments. The innovative investment model actively supports portfolio companies from the first check to the exit phase with operational expertise and network access to potential customers and partners. For more information and investment interest, visit

About Reperio Health

Reperio Health is the only at-home health assessment that provides comprehensive results immediately. Our patent-pending at-home health assessment enables employees and private individuals to perform biometric screenings at their convenience while in the comfort of their own home. For more information, visit